VitaDAO

VitaDAO is a decentralized autonomous organization (DAO) founded in 2021 by Tyler Golato to accelerate early-stage longevity science research through community governance and blockchain-based funding mechanisms. The organization pools capital from token holders to fund, acquire, and commercialize intellectual property in aging and longevity biology — including drug discovery, target identification, and preclinical development projects. VitaDAO has deployed over $4.7 million across 31 research projects spanning target discovery, drug discovery, and clinical development, and has raised funding from institutional backers including Pfizer Ventures. It operates with a decentralized membership model governed by VITA token holders and is incorporating AI-powered agents to accelerate hypothesis generation and research evaluation.